Norovirus capsid protein expressed in yeast forms virus-like particles and stimulates systemic and mucosal immunity in mice following an oral administration of raw yeast extracts

Journal of Medical Virology

Volumn 79, Issue 1, 2007, Pages 74-83

  Xia, Ming ^a   Farkas, Tibor ^a,b   Jiang, Xi ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Capsid protein; Human calicivirus; Immune response; Norovirus; Vaccine; Yeast expression

Indexed keywords

ADJUVANT; ANTIBODY; BLOOD GROUP ANTIGEN; CAPSID PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CELL LYSATE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTIGENICITY; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG SAFETY; FECES; GASTROENTERITIS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; NOROVIRUS; NUCLEOTIDE SEQUENCE; PICHIA PASTORIS; PROTEIN EXPRESSION; VIRUS CAPSID; VIRUS PARTICLE; YEAST;

ADMINISTRATION, ORAL; ANIMALS; CAPSID PROTEINS; IMMUNITY, MUCOSAL; MICE; NOROVIRUS; NORWALK VIRUS; YEASTS;

ANIMALIA; MIRIDAE; NOROVIRUS; NOROVIRUS ISOLATES; PICHIA PASTORIS;

EID: 33845406314     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20762     Document Type: Article

References (38)

1. Baim SB, Sherman F. 1988. mRNA structures influencing translation in the yeast Saccharomyces cerevisiae. Mol Cell Biol 8:1591-1601.
2. Ball JM, Hardy ME, Atmar RL, Conner ME, Estes MK. 1998. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol 72:1345-1353.
3. Baric RS, Yount B, Lindesmith L, Harrington PR, Greene SR, Tseng FC, Davis N, Johnston RE, Klapper DG, Moe CL. 2002. Expression and self-assembly of norwalk virus capsid protein from venezuelan equine encephalitis virus replicons. J Virol 76:3023-3030.
4. Black RE, Greenberg HB, Kapikian AZ, Brown KH, Becker S. 1982. Acquisition of serum antibody to Norwalk Virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh. J Infect Dis 145:483-489.
5. Blacklow NR, Cukor G, Bedigian MK, Echeverria P, Greenberg HB, Schreiber DS, Trier JS. 1979. Immune response and prevalence of antibody to Norwalk enteritis virus as determined by radioimmunoassay. J Clin Microbiol 10:903-909.
6. Clare JJ, Rayment FB, Ballantine SP, Sreekrishna K, Romanos MA. 1991a. High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene. Biotechnology (NY) 9:455-460.
7. Clare JJ, Romanos MA, Rayment FB, Rowedder JE, Smith MA, Payne MM, Sreekrishna K, Henwood CA. 1991b. Production of mouse epidermal growth factor in yeast: High-level secretion using Pichia pastoris strains containing multiple gene copies. Gene 105:205-212.
8. Dolin R, Blacklow NR, DuPont H, Formal S, Buscho RF, Kasel JA, Chames RP, Hornick R, Chanock RM. 1971. Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. J Infect Dis 123:307-312.
9. Dolin R, Blacklow NR, DuPont H, Buscho RF, Wyatt RG, Kasel JA, Hornick R, Chanock RM. 1972. Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis. Proc Soc Exp Biol Med 140:578-583.
10. Glass PJ, White LJ, Ball JM, Leparc-Goffart I, Hardy ME, Estes MK. 2000. Norwalk virus open reading frame 3 encodes a minor structural protein. J Virol 74:6581-6591.
11. Green KY, Lew JF, Jiang X, Kapikian AZ, Estes MK. 1993. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol 31:2185-2191.
12. Green KY, Kapikian AZ, Valdesuso J, Sosnovtsev S, Treanor JJ, Lew JF. 1997. Expression and self-assembly of recombinant capsid protein from the antigenically distinct Hawaii human calicivirus. J Clin Microbiol 35:1909-1914.
13. Greenberg H, Wyatt R, Kalica A. 1981. New insights in viral gastroenteritis. In: AM P, editor. Perspectives in virology. New York: Alan R. Liss. pp 163-187.
14. Guerrero R, Ball J, Estes M. 1998. Immunogenicity in mice of recombinant Norwalk virus-like particles administered by mucosal routes. J Pediatr Gastroenterol Nutr 26:547.
15. Guerrero RA, Ball JM, Krater SS, Pacheco SE, Clements JD, Estes MK. 2001. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J Virol 75:9713-9722.
16. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. 2002a. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76:12335-12343.
17. Harrington PR, Yount B, Johnston RE, Davis N, Moe C, Baric RS. 2002b. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles. J Virol 76:730-742.
18. Hennessy EP, Green AD, Connor MP, Darby R, MacDonald P. 2003. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 188:176-177.
19. Huang PW, Farkas T, Zhong WM, Tan M, Thornton S, Morrow AL, Jiang X. 2005. Norovirus and histo-blood group antigens: Demonstration of a wide spectrum of strain specificity and classification of two major binding groups among multiple binding patterns. J Virol 79:6714-6722.
20. Hutson AM, Atmar RL, Graham DY, Estes MK. 2002. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis 185:1335-1337.
21. Jiang X, Graham DY, Wang KN, Estes MK. 1990. Norwalk virus genome cloning and characterization. Science 250:1580-1583.
22. Jiang X, Wang M, Graham DY, Estes MK. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. JVirol 66:6527-6532.
23. Jiang X, Wang M, Wang K, Estes MK. 1993. Sequence and genomic organization of Norwalk virus. Virology 195:51-61.
24. Jiang X, Matson DO, Ruiz-Palacios GM, Hu J, Treanor J, Pickering LK. 1995. Expression, self-assembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein. J Clin Microbiol 33:1452-1455.
25. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, Stewart P, LePendu J, Baric R. 2003. Human susceptibility and resistance to Norwalk virus infection. Nat Med 9:548-553.
26. Lindesmith L, Moe C, Lependu J, Frelinger JA, Treanor J, Baric RS. 2005. Cellular and humoral immunity following Snow Mountain virus challenge. J Virol 79:2900-2909.
27. Mason HS, Ball JM, Shi JJ, Jiang X, Estes MK, Arntzen CJ. 1996. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci USA 93:5335-5340.
28. Nakata S, Chiba S, Terashima H, Yokoyama T, Nakao T. 1985. Humoral immunity in infants with gastroenteritis caused by human calicivirus. J Infect Dis 152:274-279.
29. Parrino TA, Schreiber DS, Trier JS, Kapikian AZ, Blacklow NR. 1977. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med 297:86-89.
30. Rockx BH, Vennema H, Hoebe CJ, Duizer E, Koopmans MP. 2005. Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis 191:749-754.
31. Romanos MA, Clare JJ, Beesley KM, Rayment FB, Ballantine SP, Makoff AJ, Dougan G, Fairweather NF, Charles IG. 1991. Recombinant Bordetella pertussis pertactin (P69) from the yeast Pichia pastoris: High-level production and immunological properties. Vaccine 9:901-906.
32. Ryder RW, Singh N, Reeves WC, Kapikian AZ, Greenberg HB, Sack RB. 1985. Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands. J Infect Dis 151:99-105.
33. Scolnick EM, McLean AA, West DJ, McAleer WJ, Miller WJ, Buynak EB. 1984. Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. JAMA 251:2812-2815.
34. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ. 2000. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 182:302-305.
35. Tan M, Zhong W, Song D, Thornton S, Jiang X. 2004. E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. J Med Virol 74:641-649.
36. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD. 1982. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298:347-350.
37. White LJ, Hardy ME, Estes MK. 1997. Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells. J Virol 71:8066-8072.
38. Wyatt RG, Dolin R, Blacklow NR, DuPont HL, Buscho RF, Thornhill TS, Kapikian AZ, Chanock RM. 1974. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J Infect Dis 129:709-714.